RXO INC (RXO)

US74982T1034 - Common Stock

19.32  -0.59 (-2.96%)

Premarket: 19.23 -0.09 (-0.47%)

Buy % Consensus

67

ChartMill assigns a Buy % Consensus number of 67% to RXO. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 20.81. This target is 7.7% above the current price.
RXO was analyzed by 19 analysts. The buy percentage consensus is at 67. So analysts seem to be have mildly positive about RXO.
In the previous month the buy percentage consensus was at a similar level.
RXO was analyzed by 19 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 19.3215.1521.4220.8126.25 - -21.58% 10.87% 7.70% 35.87%
Up and Down Grades
Date Firm Action Rating
2024-04-19 Benchmark Reiterate Hold
2024-03-26 Susquehanna Maintains Negative -> Negative
2024-03-25 Susquehanna Maintains Negative -> Negative
2024-02-13 Oppenheimer Maintains Outperform -> Outperform
2024-02-09 Susquehanna Maintains Negative -> Negative
2024-02-08 B of A Securities Downgrade Buy -> Neutral
2024-01-10 Vertical Research Downgrade Buy -> Hold
2024-01-10 Stifel Maintains Hold -> Hold
2023-10-16 Stifel Maintains Hold -> Hold
2023-10-11 JP Morgan Downgrade Neutral -> Underweight
2023-10-03 Susquehanna Maintains Negative -> Negative
2023-10-02 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-08-31 Susquehanna Downgrade Neutral -> Negative
2023-08-07 Oppenheimer Reiterate Outperform -> Outperform
2023-08-03 Stephens & Co. Maintains Equal-Weight -> Equal-Weight
2023-08-03 Morgan Stanley Reiterate Equal-Weight -> Equal-Weight
2023-07-12 Wolfe Research Downgrade Peer Perform -> Underperform
2023-07-06 Morgan Stanley Reiterate Equal-Weight -> Equal-Weight
2023-06-09 Susquehanna Initiate Neutral
2023-05-24 Barclays Initiate Overweight
2023-05-04 Wells Fargo Maintains Equal-Weight
2023-04-04 Benchmark Initiate Hold
2023-02-27 Cowen & Co. Initiate Market Perform
2023-02-09 UBS Maintains Neutral
2023-02-09 Oppenheimer Maintains Outperform
2023-02-09 Goldman Sachs Maintains Neutral
2023-02-08 Stephens & Co. Maintains Equal-Weight
2023-01-11 Stifel Downgrade Buy -> Hold
2023-01-09 JP Morgan Initiate Neutral
2022-12-20 Wells Fargo Initiate Equal-Weight